(Q36278412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Folate during antifolate chemotherapy: what we know... and do not know (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Kim Robien

series ordinal

1

1 reference

13 August 2017

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

Nutrition in Clinical Practice

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

411-422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

THE CONCENTRATION OF “FOLIC ACID”

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Karnofsky memorial lecture. Ode to methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Dihydropteroate synthase: an old drug target revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Methotrexate polyglutamate synthesis by cultured human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Anticancer Antifolates: Current Status and Future Directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

High-dose methotrexate and asparaginase for the treatment of children with acute lymphoblastic leukemia: why and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Folate, antifolates, and folate analogs in pediatric oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Defining the appropriate dosage of folinic acid after high-dose methotrexate for childhood acute lymphatic leukemia that will prevent neurotoxicity without rescuing malignant cells in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

A dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5- yl)ethyl]benzoyl]-L-glutamic acid, is an inhibitor of thymidylate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Pemetrexed (Alimta®): a novel multitargeted antifolate agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Pharmacogenetics and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Pharmacogenetics and folate metabolism -- a promising direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Pharmacogenetics of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Biological and clinical implications of the MTHFR C677T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0115426505020004411

10.1177/0115426505020004411

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16207681%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference